Literature DB >> 11994460

Visualization of lymphotoxin-beta and lymphotoxin-beta receptor expression in mouse embryos.

Jeffrey L Browning1, Lars E French.   

Abstract

The heteromeric lymphotoxin alphabeta ligand (LT) binds to the LTbeta receptor (LTbetaR) and provides an essential trigger for lymph node (LN) development. LTbetaR signaling is also critical for the emergence of pathological ectopic lymph node-like structures and the maintenance of an organized splenic white pulp. To better understand the role of LT in development, the expression patterns of LTbeta and LTbetaR mRNA were examined by in situ hybridization in the developing mouse embryo. Images of LTbeta ligand expression in developing peripheral LN in the E18.5 embryo revealed a relatively early phase structure and allowed for comparative staging with LN development in rat and humans. The LTbetaR is expressed from E16.5 onward in respiratory, salivary, bronchial, and gastric epithelium, which may be consistent with early communication events between lymphoid elements and epithelial specialization over emerging mucosal LN. Direct comparison of mouse fetal and adult tissues by FACS analysis confirmed the elevated expression of LTBR in some embryonic epithelial layers. Therefore, surface LTBR expression may be elevated during fetal development in some epithelial layers.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11994460     DOI: 10.4049/jimmunol.168.10.5079

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  32 in total

1.  A role for surface lymphotoxin in experimental autoimmune encephalomyelitis independent of LIGHT.

Authors:  Jennifer L Gommerman; Keith Giza; Stuart Perper; Irene Sizing; Apinya Ngam-Ek; Cheryl Nickerson-Nutter; Jeffrey L Browning
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

Review 2.  Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED): a model disease to study molecular aspects of endocrine autoimmunity.

Authors:  P Peterson; J Pitkänen; N Sillanpää; K Krohn
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

Review 3.  The role of LIGHT in T cell-mediated immunity.

Authors:  Jing Wang; Yang-Xin Fu
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

Review 4.  Immunoregulation by tumor necrosis factor superfamily member LIGHT.

Authors:  Yugang Wang; Mingzhao Zhu; Mendy Miller; Yang-Xin Fu
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

Review 5.  Regulating the mucosal immune system: the contrasting roles of LIGHT, HVEM, and their various partners.

Authors:  Marcos W Steinberg; Jr-Wen Shui; Carl F Ware; Mitchell Kronenberg
Journal:  Semin Immunopathol       Date:  2009-06-03       Impact factor: 9.623

Review 6.  Targeting lymphocyte activation through the lymphotoxin and LIGHT pathways.

Authors:  Carl F Ware
Journal:  Immunol Rev       Date:  2008-06       Impact factor: 12.988

7.  The lymphotoxin pathway regulates Aire-independent expression of ectopic genes and chemokines in thymic stromal cells.

Authors:  Natalie Seach; Tomoo Ueno; Anne L Fletcher; Tamara Lowen; Monika Mattesich; Christian R Engwerda; Hamish S Scott; Carl F Ware; Ann P Chidgey; Daniel H D Gray; Richard L Boyd
Journal:  J Immunol       Date:  2008-04-15       Impact factor: 5.422

Review 8.  The TNF receptor and Ig superfamily members form an integrated signaling circuit controlling dendritic cell homeostasis.

Authors:  Carl De Trez; Carl F Ware
Journal:  Cytokine Growth Factor Rev       Date:  2008-06-03       Impact factor: 7.638

9.  Herpesvirus entry mediator (HVEM) attenuates signals mediated by the lymphotoxin β receptor (LTβR) in human cells stimulated by the shared ligand LIGHT.

Authors:  John Bechill; William J Muller
Journal:  Mol Immunol       Date:  2014-06-28       Impact factor: 4.407

10.  T cell-derived lymphotoxin regulates liver regeneration.

Authors:  Alexei V Tumanov; Ekaterina P Koroleva; Peter A Christiansen; Mehtab A Khan; Matthew J Ruddy; Byron Burnette; Salvatore Papa; Guido Franzoso; Sergei A Nedospasov; Yang-Xin Fu; Robert A Anders
Journal:  Gastroenterology       Date:  2008-09-18       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.